Putting hands to rest: efficient deep CNN-RNN architecture for chemical named entity recognition with no hand-crafted rules I Korvigo, M Holmatov, A Zaikovskii, M Skoblov Journal of cheminformatics 10, 1-10, 2018 | 56 | 2018 |
Spectrum of APC and MUTYH germ‐line mutations in Russian patients with colorectal malignancies GA Yanus, TA Akhapkina, AO Ivantsov, EV Preobrazhenskaya, ... Clinical genetics 93 (5), 1015-1021, 2018 | 19 | 2018 |
Variability in lung cancer response to ALK inhibitors cannot be explained by the diversity of ALK fusion variants NV Mitiushkina, VI Tiurin, AG Iyevleva, MM Kholmatov, EA Filippova, ... Biochimie 154, 19-24, 2018 | 18 | 2018 |
Lack of response to vemurafenib in melanoma carrying BRAF K601E mutation FV Moiseyenko, VV Egorenkov, MM Kramchaninov, EV Artemieva, ... Case reports in oncology 12 (2), 339-343, 2019 | 15 | 2019 |
Comparative analysis of expression of mutant and wild-type alleles is essential for reliable PCR-based detection of MET exon 14 skipping NV Mitiushkina, MM Kholmatov, VI Tiurin, AA Romanko, OS Yatsuk, ... Biochimie 165, 267-274, 2019 | 13 | 2019 |
PCR-based detection of EGFR, ALK, KRAS and BRAF mutations in Russian patients with lung adenocarcinoma: a single-center experience. NV Mitiushkina, MM Kholmatov, AR Venina, VI Tiurin, GA Yanus, ... Neoplasma 65 (6), 972-979, 2018 | 12 | 2018 |
Content of circulating tumor DNA depends on the tumor type and the dynamics of tumor size, but is not influenced significantly by physical exercise, time of the day or recent meal ES Kuligina, R Meerovich, KA Zagorodnev, MM Kholmatov, TN Sokolova, ... Cancer Genetics 256, 165-178, 2021 | 9 | 2021 |
Exome-based search for recurrent disease-causing alleles in Russian population GA Yanus, TA Akhapkina, AJ Whitehead, IV Bizin, AG Iyevleva, ... European journal of medical genetics 62 (7), 103656, 2019 | 8 | 2019 |
Changes in the concentration of EGFR-mutated plasma DNA in the first hours of targeted therapy allow the prediction of tumor response in patients with EGFR-driven lung cancer FV Moiseyenko, ES Kuligina, AS Zhabina, SA Belukhin, TA Laidus, ... International journal of clinical oncology 27 (5), 850-862, 2022 | 3 | 2022 |
1197P Changes in the concentration of EGFR-mutated (EGFR-M+) plasma DNA in the first hours of TKI therapy allow the prediction of tumour response in patients with EGFR-M+ NSCLC ES Kuligina, FV Moiseenko, SA Belukhin, TA Laidus, AS Martianov, ... Annals of Oncology 31, S787, 2020 | | 2020 |
Presence of distant metastases and disease progression but not tumor size, lymph node involvement, circadian rhythms, prior physical exercise or recent food consumption … ES Kuligina, R Meerovich, KA Zagorodnev, MM Kholmatov, TA Laidus, ... Cancer Research 80 (16_Supplement), 717-717, 2020 | | 2020 |
Preferential expression of the affected MET allele in lung carcinomas with heterozygous MET exon 14 skipping mutations: Implications for clinical testing E Imyanitov, N Mitiushkina, M Kholmatov, V Tiurin, A Romanko, ... Annals of Oncology 30, v638-v639, 2019 | | 2019 |
PCR-based analysis of MET exon 14 skipping mutations in Russian lung cancer patients G Raskin, M Kholmatov, N Mitiushkina, V Tiurin, A Romanko, E Imyanitov VIRCHOWS ARCHIV 475, S145-S145, 2019 | | 2019 |
Advanced Parser for Biomedical Texts A Karazeev, M Holmatov, A Zaikovskii, I Korvigo, M Skoblov Moscow Conference on Computational Molecular Biology (MCCMB 2017), 137-137, 2017 | | 2017 |